Croma-Pharma
Gregor Siegel is currently serving as the Head of Commercial Excellence and SFE at CROMA-PHARMA since March 2020. In this role, they lead the local Commercial Excellence team, improves Sales Force Effectiveness, and implements data analytic projects for identifying growth opportunities. Prior to this, they worked at Novartis as a Project Manager Commercial Excellence from November 2017 to March 2020. In this role, they collaborated cross-functionally, assessed growth opportunities, analyzed marketing and sales data, and implemented new systems and processes. Before Novartis, Gregor worked at Unilever Austria GmbH as a Finance Business Partner from May 2015 to October 2017, where they were responsible for finance-related topics and business partnering. Gregor also has experience working at companies like BP, Daikin Airconditioning Central Europe HandelsgmbH, Raiffeisen Capital Management, and IKEA in various roles related to supply coordination, logistics, portfolio management, accounting, and more.
Gregor Siegel attended WU (Vienna University of Economics and Business) from 2003 to 2012. Gregor did not receive any degree or study in a specific field during their time there. In 2007, Gregor Siegel briefly attended Gies College of Business - University of Illinois Urbana-Champaign, where they focused on business and economics. However, no degree was obtained from this institution either.
This person is not in any teams
This person is not in any offices
Croma-Pharma
4 followers
Croma is a global player in the minimally invasive aesthetics market and a leading European manufacturer of premium quality hyaluronic acid syringes. The company offers a comprehensive and innovative aesthetics portfolio including botulinum toxin, fillers, lifting threads and biostimulators complemented by its own skincare brand. Founded in 1976 by a pharmacist couple, Croma-Pharma GmbH is a family company headquartered in Austria where it also operates its manufacturing plant. With 550 employees, 13 subsidiaries in Europe and Brazil, two joint ventures and 60 exclusive export partners, it distributes its products in 80 markets globally, including the US, Canada, China, Australia and New Zealand. It also operates as a contract manufacturer in orthopaedics and ophthalmology. For more information please visit cromapharma.com.